Dopaminergic properties and function after grafting of attached neural precursor cultures

Neurobiology of Disease

Volumn 21, Issue 3, 2006, Pages 587-606

  Timmer, Marco ^a,c   Grosskreutz, Julian ^a,c   Schlesinger, Friedrich ^a,c   Krampfl, Klaus ^a,c   Wesemann, Maike ^a,c   Just, Lothar ^b   Bufler, Johannes ^a,c   Grothe, Claudia ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

6 OHDA lesioned rats; Calcium imaging; Dopaminergic progenitors; In vitro differentiation; Parkinson's disease; Proliferated cells of the ventral mesencephalon; Transplantation; Tyrosine hydroxylase

Indexed keywords

AMPA RECEPTOR; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; EXPERIMENTAL MODEL; FEMALE; FETUS (ANATOMY); GENETIC MANIPULATION; IN VITRO STUDY; IN VIVO STUDY; MEDICAL ETHICS; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEWBORN; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RAT; REINNERVATION; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DOPAMINE; EMBRYO; FEMALE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NEURONS; PARKINSONIAN DISORDERS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

EID: 33244481518     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.09.003     Document Type: Article

References (64)

1. M. Abercrombie Estimation of nuclear population from microtome sections Anat. Rec. 94 1946 239 247
2. A. Bjorklund, and O. Lindvall Parkinson disease gene therapy moves toward the clinic Nat. Med. 6 2000 1207 1208
3. A. Bjorklund, U. Stenevi, R.H. Schmidt, S.B. Dunnett, and F.H. Gage Intracerebral grafting of neuronal cell suspensions: I. Introduction and general methods of preparation Acta Physiol. Scand. Suppl. 522 1983 1 7
4. P. Brundin, and A. Bjorklund Survival of expanded dopaminergic precursors is critical for clinical trials Nat. Neurosci. 1 1998 537
5. J. Bufler, F. Zufall, C. Franke, and H. Hatt Patchclamp recordings of spiking and nonspiking interneurons from rabbit olfactory bulb slices: membrane properties and ionic currents J. Comp. Physiol., A 170 1992 145 152
6. J. Bufler, C. Franke, H. Parnas, and J. Dudel Open channel block by physostigmine and procaine in embryonic like nicotinic receptors of mouse muscle Eur. J. Neurosci. 8 1996 677 687
7. S. Chung, K.C. Sonntag, T. Andersson, L.M. Bjorklund, J.J. Park, D.W. Kim, U.J. Kang, O. Isacson, and K.S. Kim Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons Eur. J. Neurosci. 16 2002 1829 1838
8. M.G. Cunningham, and R.D. McKay A hypothermic miniaturized stereotaxic instrument for surgery in newborn rats J. Neurosci. Methods 47 1-2 1993 (Apr) 105 114
9. J.S. Draper, K. Smith, P. Gokhale, H.D. Moore, E. Maltby, J. Johnson, L. Meisner, T.P. Zwaka, J.A. Thomson, and P.W. Andrews Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells Nat. Biotechnol. 22 2004 53 54
10. J. Dudel, C. Franke, and H. Hatt Rapid activation, desensitization and resensitization of synaptic channels on crayfish muscle after glutamate pulses Biophys. J. 57 1990 533 545
11. S.B. Dunnett, A. Bjorklund, and O. Lindvall Cell therapy in Parkinson's disease-Stop or go? Nat. Rev., Neurosci. 2 2001 365 369
12. F.A. Edwards, A. Konnerth, B. Sakmann, and T. Takahashi A thin slice preparation for patch clamp recordings from neurons of the mammalian central nervous system Pflugers Arch. 414 1989 600 612
13. D. Feldmeyer, K. Kask, R. Brusa, H.C. Kornau, R. Kolhekar, A. Rozov, N. Burnashev, V. Jensen, O. Hvalby, R. Sprengel, and P.H. Seeburg Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B Nat. Neurosci. 2 1999 57 64
14. H.C. Fibiger, and A.G. Phillips Mesocorticolimbic dopamine systems and reward Ann. N. Y. Acad. Sci. 537 1988 206 215
15. C. Franke, H. Hatt, and J. Dudel Liquid filament switch for ultra fast exchanges of solutions at excised patches of synaptic membrane of crayfish muscle Neurosci. Lett. 77 1987 199 204
16. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg, and S. Fahn Transplantation of embryonic dopamine neurons for severe Parkinson's disease N. Engl. J. Med. 344 2001 710 719
17. S. Fuhrmann, M. Kirsch, K. Wewetzer, and H.D. Hofmann Use of cell ELISA for the screening of neurotrophic activities on minor cell populations in retinal monolayer cultures J. Neurosci. Methods 75 2 1997 199 205 Aug. 22
18. C. Grothe, A. Schulze, I. Semkova, F. Muller-Ostermeyer, A. Rege, and K. Wewetzer The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro Neuroscience 100 2000 73 86
19. C. Grothe, C. Meisinger, and P. Claus In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia J. Comp. Neurol. 434 2001 342 357
20. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
21. P. Hagell, P. Piccini, A. Bjorklund, P. Brundin, S. Rehncrona, H. Widner, L. Crabb, N. Pavese, W.H. Oertel, N. Quinn, D.J. Brooks, and O. Lindvall Dyskinesias following neural transplantation in Parkinson's disease Nat. Neurosci. 5 2002 627 628
22. O.P. Hamill, A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth Improved patchclamp techniques for high resolution current recordings from cells and cell free patches Pflugers Arch. 391 1981 85 100
23. M. Heckmann, J. Bufler, C. Franke, and J. Dudel Kinetics of homomeric GluR6 glutamate receptor channels Biophys. J. 71 1996 1743 1750
24. M.J. Hurley, D.C. Mash, and P. Jenner Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR Eur. J. Neurosci. 18 9 2003 (Nov) 2668 2672
25. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression Neuron 12 1994 1281 1289
26. J.H. Kim, J.M. Auerbach, J.A. Rodriguez-Gomez, I. Velasco, D. Gavin, N. Lumelsky, S.H. Lee, J. Nguyen, R. Sanchez-Pernaute, K. Bankiewicz, and R. McKay Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease Nature 418 2002 50 56
27. J.Y. Kim, H.C. Koh, J.Y. Lee, M.Y. Chang, Y.C. Kim, H.Y. Chung, H. Son, Y.S. Lee, L. Studer, R. McKay, and S.H. Lee Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression J. Neurochem. 85 2003 1443 1454
28. T.E. Kim, H.S. Lee, Y.B. Lee, S.H. Hong, Y.S. Lee, H. Ichinose, S.U. Kim, and M.A. Lee Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell Biochem. Biophys. Res. Commun. 305 2003 1040 1048
29. N. Konig, S. Poluch, J. Estabel, M. Durand, M.J. Drian, and J.M. Exbrayat Synaptic and non-synaptic AMPA receptors permeable to calcium Jpn. J. Pharmacol. 86 2001 1 17
30. G.F. Koob, and N.R. Swerdlow The functional output of the mesolimbic dopamine system Ann. N. Y. Acad. Sci. 537 1988 216 227
31. S.H. Lee, N. Lumelsky, L. Studer, J.M. Auerbach, and R.D. McKay Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells Nat. Biotechnol. 18 2000 675 679
32. O. Lindvall, and P. Hagell Clinical observations after neural transplantation in Parkinson's disease Prog. Brain Res. 127 2000 299 320
33. O. Lindvall, Z. Kokaia, and A. Martinez-Serrano Stem cell therapy for human neurodegenerative disorders-How to make it work Nat. Med. 10 2004 S42 S50 Suppl
34. Z.D. Ling, E.D. Potter, J.W. Lipton, and P.M. Carvey Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines Exp. Neurol. 149 1998 411 423
35. H. Lomeli, J. Mosbacher, T. Melcher, T. Hoger, J.R. Geiger, T. Kuner, H. Monyer, M. Higuchi, A. Bach, and P.H. Seeburg Control of kinetic properties of AMPA receptor channels by nuclear RNA editing Science 266 1994 1709 1713
36. C. Meisinger, C. Zeschnigk, and C. Grothe In vivo and in vitro effect of glucocorticoids on fibroblast growth factor (FGF)-2 and FGF receptor 1 expression J. Biol. Chem. 271 1996 16520 16525
37. F. Müller-Ostermeyer, P. Claus, and C. Grothe Distinctive effects of rat fibroblast growth factor-2 isoforms on PC12 and Schwann cells Growth Factors 19 2001 175 191
38. N. Nakao, E.M. Frodl, W.M. Duan, H. Widner, and P. Brundin Lazaroids improve the survival of grafted rat embryonic dopamine neurons Proc. Natl. Acad. Sci. U. S. A. 91 1994 12408 12412
39. G. Nikkhah, M.G. Cunningham, A. Jodicke, U. Knappe, and A. Bjorklund Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model Brain Res. 633 1994 133 143
40. G. Nikkhah, M. Olsson, J. Eberhard, C. Bentlage, M.G. Cunningham, and A. Bjorklund A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology Neuroscience 63 1994 57 72
41. G. Nikkhah, C. Winkler, and A. Rödter Microtransplantation of nigral dopaminergic neurons: a "step by step" recipe Cell and Tissue Transplantation in the CNS 1999 The Humana Press Totowa
42. F. Nishimura, M. Yoshikawa, S. Kanda, M. Nonaka, H. Yokota, A. Shiroi, H. Nakase, H. Hirabayashi, Y. Ouji, J. Birumachi, S. Ishizaka, and T. Sakaki Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells Stem Cells 21 2003 171 180
43. C.W. Olanow, J.H. Kordower, and T.B. Freeman Fetal nigral transplantation as a therapy for Parkinson's disease Trends Neurosci. 19 1996 102 109
44. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, M.F. Brin, K.M. Shannon, G.M. Nauert, D.P. Perl, J. Godbold, and T.B. Freeman A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann. Neurol. 54 2003 403 414
45. T. Ostenfeld, E. Joly, Y.T. Tai, A. Peters, M. Caldwell, E. Jauniaux, and C.N. Svendsen Regional specification of rodent and human neurospheres Brain Res. Dev. Brain Res. 134 2002 43 55
46. G. Paxinos, and C. Watson The Rat Brain in Stereotactic Coordinates 1999 Academic Press San Diego
47. A.E. Peaire, T. Takeshima, J.M. Johnston, K. Isoe, K. Nakashima, and J.W. Commissiong Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease J. Neurosci. Methods 124 2003 61 74
48. C. Perrone-Capano, and U. di Porzio Epigenetic factors and midbrain dopaminergic neurone development BioEssays 18 1996 817 824
49. C. Rosenblad, A. Martinez-Serrano, and A. Bjorklund Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts Neuroscience 75 1996 979 985
50. L. Roybon, N.S. Christophersen, P. Brundin, and J.Y. Li Stem cell therapy for Parkinson's disease: where do we stand? Cell Tissue Res. 318 2004 261 273
51. F. Schlesinger, J. Meywirth, K. Krampfl, J. Grosskreutz, S. Petri, C. Mauth, L. Just, A. Bader, and J. Bufler Ligand-gated channels in early mesencephalic neuronal precursors: immunocytochemical and electrophysiological analysis Eur. J. Neurosci. 19 2004 2371 2376
52. S.R. Sinclair, J.W. Fawcett, and S.B. Dunnett Dopamine cells in nigral grafts differentiate prior to implantation Eur. J. Neurosci. 11 1999 4341 4348
53. A. Storch, G. Paul, M. Csete, B.O. Boehm, P.M. Carvey, A. Kupsch, and J. Schwarz Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells Exp. Neurol. 170 2001 317 325
54. A. Storch, H.A. Lester, B.O. Boehm, and J. Schwarz Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells J. Chem. Neuroanat. 26 2003 133 142
55. L. Studer, V. Tabar, and R.D. McKay Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats Nat. Neurosci. 1 1998 290 295
56. L. Studer, M. Csete, S.H. Lee, N. Kabbani, J. Walikonis, B. Wold, and R. McKay Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J. Neurosci. 20 2000 7377 7383
57. M. Timmer, F. Muller-Ostermeyer, V. Kloth, C. Winkler, C. Grothe, and G. Nikkhah Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms Exp. Neurol. 187 2004 118 136
58. U. Ungerstedt 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome Pharmacol. Ther., B 2 1976 37 40
59. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
60. F. Volpicelli, C. Perrone-Capano, P. Da Pozzo, L. Colucci-D'Amato, and U. di Porzio Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones J. Neurochem. 88 2004 1283 1294
61. C. Winkler, H. Sauer, C.S. Lee, and A. Bjorklund Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease J. Neurosci. 16 1996 7206 7215
62. C. Winkler, D. Kirik, and A. Björklund Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci. 28 2 2005 86 92 (Review)
63. J. Yan, L. Studer, and R.D. McKay Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors J. Neurochem. 76 2001 307 311
64. W.M. Zawada, D.J. Zastrow, E.D. Clarkson, F.S. Adams, K.P. Bell, and C.R. Freed Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats Brain Res. 786 1998 96 103